BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11072524)

  • 1. [Can thrombosis be prevented through immediate postoperative low-molecular-weight-heparin prophylaxis?].
    Bank I; Büller HR
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2031. PubMed ID: 11072524
    [No Abstract]   [Full Text] [Related]  

  • 2. [When long-term marcumar administration is needed. Low-molecular-weight heparin bridges the surgery gap].
    MMW Fortschr Med; 2001 Feb; 143(8):52. PubMed ID: 11265545
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low molecular heparin in the prophylaxis of postoperative thrombosis].
    Suomalainen O
    Duodecim; 1996; 112(17):1545-51. PubMed ID: 10596143
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of catheter-related thrombosis after cardiac surgery: Is heparin the answer?
    Meyer AD; Jacobs BR
    Pediatr Crit Care Med; 2010 Jul; 11(4):531-2. PubMed ID: 20606557
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prophylaxis of postoperative thromboembolism. New alternatives to low-molecular-weight heparin].
    Bergqvist D; Siegbahn A
    Lakartidningen; 2002 Jul; 99(28-29):3039-41. PubMed ID: 12170516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal long-term treatment of venous thromboembolism.
    Prandoni P
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is anticoagulation with heparins in phenprocoumon treated patients safe during operations?].
    Hoppe UC
    Dtsch Med Wochenschr; 2002 Nov; 127(44):2345. PubMed ID: 12410442
    [No Abstract]   [Full Text] [Related]  

  • 9. [LMWH and UFH in direct comparison. Consent: CERTIFY].
    MMW Fortschr Med; 2007 May; 149(20):53. PubMed ID: 18051967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
    Schulman S
    Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
    [No Abstract]   [Full Text] [Related]  

  • 11. Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism.
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Ciccarese M; Papaldo P; Fabi A; Cognetti F
    Thromb Res; 2007; 119(4):525-9. PubMed ID: 16780933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of venous thromboembolism in orthopedic surgery and traumatology].
    Agnelli G; Cimminiello C
    Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706
    [No Abstract]   [Full Text] [Related]  

  • 14. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 15. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraoperative administration of low-molecular-weight heparins in reconstructive vascular operations].
    Pokrovskiĭ AV; Demidova VS; Titova MI; Gontarenko VN; Burtseva EA
    Angiol Sosud Khir; 2008; 14(3):11-7. PubMed ID: 19791426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Caution for prophylaxis of thrombosis in connection with spinal anesthesia. Risk of hemorrhage when low-molecular-weight heparin is administered in epidural/spinal anesthesia].
    Bergqvist D; Wiklund L
    Lakartidningen; 2000 Dec; 97(49):5762, 5765. PubMed ID: 11188033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-molecular weight heparin. A new agent to prevent thrombosis].
    Christiansen HM; Borris LC; Lassen MR
    Ugeskr Laeger; 1989 May; 151(21):1302-5. PubMed ID: 2544058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comments about dosing of low molecular weight heparins (LMWH)].
    Udvardy M; Rák K
    Orv Hetil; 2001 Sep; 142(38):2077-82. PubMed ID: 11697064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.